How can you advise patients taking ruxolitinib for vitiligo on looking for signs of repigmentation

Featuring Benjamin Lockshin, MD | EVP of Strategic Initiatives Director of the Clinical Trials Center Assistant Professor US Dermatology Partners Georgetown University Rockville, MD | Published July 01, 2024